ARCHIVES

Patient Groups Are Focus of New Alliances In a Shift of Cancer Advocacy Agenda

This article is from The Cancer Letter archive.

Vol. 22 No. 22 | May 31, 1996

Download PDF Visit The Full Archive

Related Articles

CDC Contribution To National Dialogue Raises Questions About Ties With ACS.

September 22, 2000

Fewer, Larger RT Doses Cut Recurrence Of Early Breast Cancer, UK Study Finds

June 29, 2007

NCI Seeks Nominations For Consumer Liaison Group.

November 23, 2001

NCI Cooperative Group, Cancer Center Trials Listed

October 28, 2005

NCI-Approved Clinical Trials

October 29, 2004

EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure.

March 2, 2007